Acute Myeloid Leukemia
Showing NaN - NaN of 58
Acute Myeloid Leukemia, High-risk Myelodysplastic Syndrome Trial in Poland, United States (RVU120(SEL120))
Recruiting
- Acute Myeloid Leukemia
- High-risk Myelodysplastic Syndrome
-
Miami, Florida
- +6 more
Nov 5, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))
Recruiting
- Acute Myeloid Leukemia
- +4 more
- TregGraft (Orca-T)
-
Duarte, California
- +13 more
Oct 28, 2021
Acute Myeloid Leukemia Trial in United States (CX-01, Idarubicin, Cytarabine)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
-
New Haven, Connecticut
- +2 more
Sep 8, 2021
Acute Myeloid Leukemia Trial in Worldwide (guadecitabine, Treatment Choice (TC))
Completed
- Acute Myeloid Leukemia
- guadecitabine
- Treatment Choice (TC)
-
Los Angeles, California
- +94 more
Sep 5, 2021
Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United
Completed
- Acute Myeloid Leukemia
- +27 more
- Caspofungin Acetate
- +2 more
-
Birmingham, Alabama
- +178 more
Mar 26, 2021
Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- Standard of Care
-
La Jolla, California
- +18 more
Mar 12, 2021
Acute Myeloid Leukemia, MDS Trial in Nashville, San Antonio (biological, drug, procedure)
Terminated
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- rivogenlecleucel
- +3 more
-
Nashville, Tennessee
- +1 more
Nov 11, 2020
Acute Myeloid Leukemia Trial in United States (Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A, Phase II- Sequence B)
Terminated
- Acute Myeloid Leukemia
- Phase I- Cytarabine & Eltrombopag
- +2 more
-
Worcester, Massachusetts
- +4 more
Oct 14, 2020
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Uveal Melanoma Trial in Denver, Portland, Nashville (BPX-701, Rimiducid)
Unknown status
- Acute Myeloid Leukemia
- +2 more
- BPX-701
- Rimiducid
-
Denver, Colorado
- +2 more
Apr 23, 2020
Acute Myeloid Leukemia Trial in Worldwide (PF-04449913, Low dose ARA-C (LDAC), Decitabine)
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in United States (ASTX727 + Day 2 Food, ASTX727 + Day 4 Food)
Completed
- Myelodysplastic Syndromes
- +2 more
- ASTX727 + Day 2 Food
- ASTX727 + Day 4 Food
-
Buffalo, New York
- +3 more
Feb 16, 2020
Acute Myeloid Leukemia Trial in Worldwide (Compound AC220)
Completed
- Acute Myeloid Leukemia
- Compound AC220
-
San Francisco, California
- +84 more
Dec 3, 2019
Acute Myeloid Leukemia, MDS Trial in United States (ALRN-6924, ALRN-6924 in combination with cytarabine)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- ALRN-6924
- ALRN-6924 in combination with cytarabine
-
Denver, Colorado
- +5 more
Nov 18, 2019
Acute Myeloid Leukemia Trial in Worldwide (Cytarabine or Supportive Care, Dacogen (decitabine) only)
Completed
- Acute Myeloid Leukemia
- Cytarabine or Supportive Care
- Dacogen (decitabine) only
-
Los Angeles, California
- +107 more
Aug 29, 2019
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Los Angeles, California
- +7 more
Jun 25, 2019
Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Canada, United States (Azacitidine, Lenalidomide, Best Supportive
Completed
- Acute Myeloid Leukemia
- Acute Myelogenous Leukemia
- Azacitidine
- +2 more
-
Tucson, Arizona
- +29 more
Jun 17, 2019
Acute Myeloid Leukemia Trial in Germany, Italy, United States (Gilteritinib, Voriconazole, Midazolam)
Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in Canada, United States (procedure, drug, other)
Completed
- Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +5 more
-
Birmingham, Alabama
- +446 more
Nov 28, 2018
Acute Myeloid Leukemia Trial in Worldwide (33A, , azacitidine)
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Canada, United States (Co-ArgI-PEG modified human arginase I)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Co-ArgI-PEG modified human arginase I
-
Ann Arbor, Michigan
- +9 more
Oct 15, 2018
Acute Myeloid Leukemia Trial in Worldwide (vosaroxin + cytarabine, + cytarabine)
Completed
- Acute Myeloid Leukemia
- vosaroxin + cytarabine
- placebo + cytarabine
-
La Jolla, California
- +123 more
Jul 25, 2018